Chambal Fertilisers EBITDA rises 12% in Q1FY27 on margin expansion
Chambal Fertilisers & Chemicals Limited saw standalone EBITDA rise 12% to ₹850.9 crore in Q1FY27, with PAT up 10% to ₹703.5 crore. Margin expansion offset revenue declines. Consolidated PAT dropped 5% due to IMACID losses. The company is progressing with its new urea plant under NIPU2026 and expanding its biologicals portfolio.

*this image is generated using AI for illustrative purposes only.
Chambal Fertilisers & Chemicals Limited reported a 12% year-on-year increase in standalone EBITDA to ₹850.9 crore for the quarter ended June 30, 2026 (Q1FY27), driven by significant margin expansion that offset a decline in top-line revenue. Standalone net profit after tax (PAT) rose 10% to ₹703.5 crore, while consolidated PAT declined 5% to ₹523.6 crore, primarily due to losses from its joint venture, Indo Maroc Phosphore S.A. (IMACID). The company’s standalone EBITDA margin improved to 16.93% from 13.36% in Q1FY26, demonstrating strong operational efficiency despite a 12% drop in operating income to ₹5,027 crore.
The unaudited financial results were filed with the stock exchanges under Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. An earnings call held on July 31, 2026, provided further details on segment performance and strategic initiatives. Managing Director Abhay Baijal and CFO Anuj Jain highlighted that margin improvement was supported by cost efficiencies and favorable mix shifts in Crop Protection Chemicals (CPC) and Speciality Nutrients (SN). However, urea volumes remained lower than expected due to planned shutdowns at the Gadepan plants.
Financial Performance
Standalone operational income fell to ₹5,027 crore from ₹5,698 crore in Q1FY26, primarily due to lower urea volumes. Despite this, expenses decreased by 15% to ₹4,176 crore, contributing to the EBITDA growth. Consolidated figures show a similar trend, with EBITDA rising 12% to ₹850.8 crore. The decline in consolidated PAT was largely attributed to a ₹25.1 crore loss from IMACID, compared to a ₹36.1 crore profit in the same period last year. IMACID resumed production in July 2026 after a prolonged shutdown caused by sulfur shortages and high prices.
| Metric | Q1FY27 Standalone | Q1FY26 Standalone | YoY Change |
|---|---|---|---|
| Operating Income | ₹5,027 crore | ₹5,698 crore | -12% |
| EBITDA | ₹850.9 crore | ₹761.2 crore | +12% |
| PAT | ₹703.5 crore | ₹638.0 crore | +10% |
| EPS (Basic) | ₹17.56 | ₹15.92 | +10% |
Operational Updates
Chambal Fertilisers is advancing its new urea plant project under the National Investment Policy for Urea-2026 (NIPU2026). Site enabling activities, including fencing and geo-technical studies, are complete, and environmental clearance is in progress. The company has received in-principle approval from gas suppliers and expects technical bid submissions from LSTK/EPC bidders shortly. Post-completion, CFCL aims to become the largest single-location urea producer in India.
In the biologicals segment, the company launched "Uttam Superrhiza" and "Uttam Pranaam," covering 3 million acres. It also introduced seven new CPC products and two seed varieties (Maize and Bajra). The joint venture with TERI, the CFCL-TERI Centre of Excellence, is developing 10 novel products, with five slated for launch in FY28-29.
What the Numbers Show
The divergence between standalone and consolidated performance highlights the volatility of the joint venture segment. While core operations delivered robust margin expansion (EBITDA margin up 3.57 percentage points), the IMACID loss dragged down overall group profitability. This underscores the company’s strategic focus on reducing dependency on volatile raw material markets through vertical integration and domestic capacity expansion. The near-zero net debt-to-equity ratio of 0.01% as of FY26 provides a strong balance sheet foundation for future capital expenditures.
Historical Stock Returns for Chambal Fertilisers & Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.43% | -2.53% | -2.50% | -4.91% | -23.24% | +28.05% |
How will the completion of the new NIPU2026 urea plant impact Chambal Fertilisers' market share and pricing power in the domestic urea sector?
What is the expected timeline for IMACID to return to profitability, and how might the recent resolution of sulfur supply issues affect its long-term viability?
To what extent will the new biologicals and CPC product launches contribute to revenue growth in FY28, given the current low base in those segments?


































